Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
67 Results Found
Trump administration announces new tariff plan
The Trump administration April 2 announced the implementation of a new tariff plan that will impose a 10% universal tariff on imported goods from all countries beginning April 5.
ASPR to invest in domestic production of ingredient for pain management, overdose reversal medications
The Administration for Strategic Preparedness and Response announced March 5 that it will inves
CMS announces actions addressing fraud
The Centers for Medicare & Medicaid Services Feb. 25 released a request for information on potential regulatory changes in a possible future proposed rule called Comprehensive Regulations to Uncover Suspicious Healthcare, or CRUSH.
Supreme Court strikes down tariffs imposed under IEEPA
The Supreme Court Feb. 20 ruled that the International Emergency Economic Powers Act does not authorize the imposition of global tariffs.
CMS seeks input on strengthening domestic supply chains for PPE, essential medicines
The Centers for Medicare & Medicaid Services Jan.
Olympus expands recall of endoscope needles
Olympus has expanded a voluntary recall of its ViziShot 2 FLEX Needles due to complaints of device components ejecting or attaching during procedures, the Food and Drug Administration announced Jan. 16. The company said it received reports of one patient death and one patient injury and advised users to cease use of the product immediately and quarantine all devices. Customers were instructed to return the devices to Olympus. The FDA announced a Class I recall of certain lots of the product in September.
U.S. reaches trade agreement with U.K. on drug pricing
The Trump administration announced a trade agreement with the U.K. Dec. 1 on pharmaceuticals that exempts U.K. drug products from Section 232 tariffs. In exchange, the U.K. will increase the net price it pays for new medicines by 25%.
AHA expresses concerns on potential tariffs for PPE, other medical goods
The AHA urged the Department of Commerce Oct. 17 to take a balanced approach to ensuring dependable and affordable access to personal protective equipment, medical consumables and medical equipment as it considers future tariff and trade policy.
Resource hub features tools, information on tariffs impacting health care supply chain
The AHA’s Association for Health Care Resource & Materials Management has created a webpage featuring resources on tariffs impacting the health care supply chain, including an infographic on the current state of the supply chain and a recorded presentation on using risk intelligence and analytics platforms for global supply chain monitoring.
AHA calls for Senate committee to strengthen supply chain for pharmaceuticals, medical devices
The AHA provided a statement of recor to the Senate Special Committee on Aging for a hearing Oct. 8 on the pharmaceutical and medical device supply chains.